ERBB2 and breast cancer: When comparing TOR1B expression among the four breast cancer subtypes, no significant difference was found between Luminal A and Her2-enriched subtypes, while differences in TOR1B expression levels were observed among the remaining subtypes, indicating significant variability in TOR1B expression across different breast cancer classifications (Fig. 1B, Supplementary Material 2).